TNF and ulcerative colitis: At present, treatment of mild to moderate ulcerative colitis involves, primarily, 5-aminosalicylates, while thiopurines or biological agents (anti-tumor necrosis factor alpha or anti-integrin therapy) are used for moderate to severe disease.